Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collaboration with Immunocore in Oral Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023
/PRNewswire/ -- Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer...
United States Immunocore Imm Peter Joyce Bispecific Imm American Association Of Cancer Research New Data Demonstrate Ability
Source: prnewswire.com